Exploring substance use as rule-violating behaviour during inpatient treatment of offender patients with schizophrenia

被引:4
|
作者
Sonnweber, Martina [1 ]
Kirchebner, Johannes [1 ]
Guenther, Moritz Philipp [2 ]
Kappes, Johannes Rene [1 ]
Lau, Steffen [1 ]
机构
[1] Univ Hosp Zurich, Dept Forens Psychiat, Psychiat, Zurich, Switzerland
[2] Univ Hosp Zurich, Dept Consultat Liaison Psychiat & Psychosomat Med, Zurich, Switzerland
关键词
rule-violations; schizophrenia; substance misuse; PSYCHIATRIC-PATIENTS; MENTAL-ILLNESS; DISORDERS; MISUSE; ABUSE; AGGRESSION; PREVALENCE; VIOLENCE; HEALTH;
D O I
10.1002/cbm.2245
中图分类号
DF [法律]; D9 [法律];
学科分类号
0301 ;
摘要
Background Rule-violating behaviour in the form of substance misuse has been studied primarily within the context of prison settings, but not in forensic psychiatric settings. Aims Our aim was to explore factors that are associated with substance misuse during hospitalisation in patients among those patients in a Swiss forensic psychiatric inpatient unit who were suffering from a disorder along the schizophrenia spectrum. Methods From a database of demographic, clinical and offending data on all residents at any time between 1982 and 2016 in the forensic psychiatric hospital in Zurich, 364 cases fulfilled diagnostic criteria for schizophrenia or a schizophrenia-like illness and formed our sample. Any confirmed use of alcohol or illicit substances during admission (yes/no) was the dependent variable. Its relationship to all 507 other variables was explored by machine learning. To counteract overfitting, data were divided into training and validation set. The best model from the training set was tested on the validation set. Results Substance use as a secure hospital inpatient was unusual (15, 14%). Prior substance use disorder accounted for so much of the variance (AUC 0.92) that it was noted but excluded from further models. In the resulting model of best fit, variables related to rule breaking, younger age overall and at onset of schizophrenia and nature of offending behaviour, substance misuse as a minor and having records of complications in prior psychiatric treatment were associated with substance misuse during hospitalisation, as was length of inpatient treatment. In the initial model the AUC was 0.92. Even after removal of substance use disorder from the final model, performance indicators were meaningful with a balanced accuracy of 67.95, an AUC of 0.735, a sensitivity of 81.48% and a specificity of 57.58%. Conclusions Substance misuse in secure forensic psychiatric hospitals is unusual but worthy of clinical and research consideration because of its association with other rule violations and longer hospitalisation. More knowledge is needed about effective interventions and rehabilitation for this group.
引用
收藏
页码:255 / 266
页数:12
相关论文
共 28 条
  • [1] Treatment Outcomes of an Integrated Residential Programme for Patients with Schizophrenia and Substance Use Disorder
    Morrens, Manuel
    Dewilde, Bieke
    Sabbe, Bernard
    Dom, Geert
    De Cuyper, Raoul
    Moggi, Franz
    EUROPEAN ADDICTION RESEARCH, 2011, 17 (03) : 154 - 163
  • [2] Treatment of patients with schizophrenia and comorbid substance use disorders
    Dilbaz, Nesrin
    Darcin, Asli Enez
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 21 (01): : 80 - 90
  • [3] Strategies to cope with treatment in substance use disorder male patients with and without schizophrenia
    Marquez-Arrico, Julia E.
    Benaiges, Irina
    Adan, Ana
    PSYCHIATRY RESEARCH, 2015, 228 (03) : 752 - 759
  • [4] Correlates of optimism among patients in substance use disorder inpatient treatment
    Provost, Scott E.
    Griffin, Margaret L.
    Hilton, Blake T.
    McHugh, R. Kathryn
    Taghian, Nadine R.
    Trinh, Catherine D.
    Weiss, Roger D.
    AMERICAN JOURNAL ON ADDICTIONS, 2022, 31 (06) : 494 - 501
  • [5] Referral to aftercare following inpatient withdrawal treatment and readmission: retrospective chart review of patients with substance use disorders
    Habermeyer, Benedikt
    Lay, Barbara
    Scherbaum, Norbert
    Bonnet, Udo
    Roser, Patrik
    SWISS MEDICAL WEEKLY, 2022, 152
  • [6] Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy
    Potvin, Stephane
    Kouassi, Edouard
    Lipp, Olivier
    Bouchard, Roch-Hugo
    Roy, Marc-Andre
    Demers, Marie-France
    Gendron, Alain
    Astarita, Giuseppe
    Piomelli, Daniele
    Stip, Emmanuel
    JOURNAL OF PSYCHOPHARMACOLOGY, 2008, 22 (03) : 262 - 269
  • [7] Psychosocial factors associated with coping behaviour after inpatient treatment for substance use disorder: a systematic review study protocol
    Johannessen, Dagny Adriaenssen
    Nordfjaern, Trond
    Geirdal, Amy Ostertun
    BMJ OPEN, 2019, 9 (01):
  • [8] Co-occurring compulsive sexual behaviour in an inpatient substance use population: Clinical correlates and influence on treatment outcomes
    Snaychuk, Lindsey A.
    Dermody, Sarah S.
    Tabri, Nassim
    Basedow, Christina A.
    Kim, Hyoun S.
    JOURNAL OF BEHAVIORAL ADDICTIONS, 2024, 13 (02) : 676 - 686
  • [9] Domains and Perceived Benefits of Treatment Among Patients With and Without Co-Occurring Disorders in Inpatient Substance Use Treatment
    Bergly, Tone H.
    Grawe, Rolf W.
    Hagen, Roger
    JOURNAL OF DUAL DIAGNOSIS, 2014, 10 (02) : 91 - 97
  • [10] Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study
    Chiappini, Stefania
    Mosca, Alessio
    Miuli, Andrea
    Di Carlo, Francesco
    d'Andrea, Giacomo
    Napolitano, Alessandra
    Santangelo, Monica
    Esposito, Corradina
    Rosazza, Anna
    Haefele, Elena
    Di Petta, Gilberto
    Pettorruso, Mauro
    Sensi, Stefano L.
    Martinotti, Giovanni
    ADVANCES IN DUAL DIAGNOSIS, 2023, 16 (03) : 185 - 198